Goldenrod Therapeutics

Houston, United States

Goldenrod Therapeutics develops a small molecule to prevent pathogenic activity in immune cells.

$6.5M raised

Jun 2026

Seed

Biotechnology Health Care Therapeutics

Top Investors

Ataxia Ventures Fannin Innovation Studio

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Goldenrod Therapeutics

How much funding has Goldenrod Therapeutics raised?

Goldenrod Therapeutics has raised $6.5M in total funding. The most recent round was Seed. The last funding was announced in June 2026.

Who are Goldenrod Therapeutics's investors?

Goldenrod Therapeutics's investors include Ataxia Ventures, Fannin Innovation Studio.

Where is Goldenrod Therapeutics headquartered?

Goldenrod Therapeutics is headquartered in Houston, United States.

What does Goldenrod Therapeutics do?

Goldenrod Therapeutics develops a small molecule to prevent pathogenic activity in immune cells.

What stage is Goldenrod Therapeutics at?

Goldenrod Therapeutics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 4, 2026.

MLA

"Goldenrod Therapeutics — Funding & Investors." VCBacked, June 4, 2026, https://www.vcbacked.co/company/goldenrod-therapeutics. Accessed July 3, 2026.

APA

VCBacked. (2026). Goldenrod Therapeutics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/goldenrod-therapeutics

Wikipedia (cite web)

{{cite web |title=Goldenrod Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/goldenrod-therapeutics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 4, 2026.